Total Funding
42
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
116238
Solsys Medical manufactures a line of wound care products including a biologically active cryopreserved real human skin allograft.
Acquired by 
Misonix
Michael Weber: Director, R&D / QAPast Role: Amgen Ventures, QA Specialist
Thomas McCarter: Chief Executive OfficerPast Role: Johnson & Johnson, Director/President/Regional VP
About the Company
Solsys Medical manufactures and distributes a line of wound care products. Its products include a biologically active cryopreserved real human skin allograft for healing in non-progressing chronic wounds, such as diabetic foot ulcers, venous stasis ulcers, dehisced surgical wounds, and pressure ulcers; and a pre-moistened nonadherent polymer wound
interface dressing for treating various wounds, including diabetic foot ulcers, venous stasis ulcers, dehisced wounds, skin tears, pressure sores, and burns. Solsys Medical, LLC (formerly known as Soluble Systems)
